Core Viewpoint - Qingyue Technology (688496) is under investigation by the China Securities Regulatory Commission (CSRC) for suspected false reporting of financial data, which may lead to significant legal consequences including potential delisting [1][3] Company Announcements Summary - Qingyue Technology received a notice from the CSRC on November 1, 2025, regarding the investigation for suspected false financial reporting, and the investigation is still ongoing with no conclusive opinions or decisions received yet [1][3] - The company has been actively cooperating with the investigation and is required to disclose risk announcements monthly, with designated media for information disclosure being the Shanghai Stock Exchange website and several financial newspapers [1] - As a result of the investigation, three securities accounts holding a total of 1,631,343 shares (all repurchased shares) and seven bank accounts with a total of 133,644,123.04 yuan in frozen funds (all related to fundraising) have been frozen [1][3]

Core Viewpoint - Qingyue Technology (688496.SH) is under investigation by the China Securities Regulatory Commission (CSRC) for suspected false reporting of financial data, which may lead to mandatory delisting if found guilty [1] Group 1: Investigation and Regulatory Actions - The company has been formally investigated by the CSRC for alleged false records in periodic reports [1] - If the CSRC confirms violations that meet the criteria for mandatory delisting as per the Shanghai Stock Exchange's rules, the company's stock may face significant delisting consequences [1] Group 2: Asset Freezing - On February 4, 2026, the company received a freezing order from the CSRC, which affects three securities accounts holding a total of 1.631343 million shares, all of which were repurchased by the company [1] - Additionally, seven bank accounts, designated for fundraising purposes, have been frozen, totaling 134 million yuan in principal [1] - The freezing measures do not impact the company's other bank accounts and are not expected to significantly affect normal business operations [1]

Core Viewpoint - Qingyue Technology (688496) is currently under investigation by the China Securities Regulatory Commission (CSRC) for suspected false reporting of financial data, which may lead to significant legal consequences, including potential delisting if violations are confirmed [1][3]. Company Announcements - Qingyue Technology's stock closed at 6.11 yuan on January 9, 2026, up 2.86% from the previous week, with a market capitalization of 2.75 billion yuan, ranking 89th in the optical optoelectronics sector [1]. - The company held its first extraordinary general meeting of shareholders for 2026 on January 9, 2026, where two key proposals regarding the estimated bank credit limit and guarantee limit for 2026 were approved with over 99% support from shareholders present [2][3]. - The meeting was attended by 57 shareholders, representing 358,020,988 voting shares, which accounted for 79.8497% of the total voting rights [2].

Core Viewpoint - Long Pharmaceutical Holdings (长药控股) is facing legal actions due to allegations of false financial reporting and significant financial irregularities, with ongoing investor compensation claims being processed through the courts [1][3]. Group 1: Legal Proceedings - The law firm Shanghai Jucheng has submitted multiple claims to the Wuhan Intermediate People's Court on behalf of investors against Long Pharmaceutical Holdings, with previous successful cases serving as a precedent [1][3]. - The firm continues to accept claims from other investors who have suffered losses related to the company's stock [3]. Group 2: Financial Irregularities - Long Pharmaceutical Holdings announced on April 30, 2024, that it is under scrutiny for fund misappropriation and illegal guarantees, with an audit report highlighting significant uncertainties regarding its ongoing operations [4]. - The company reported a fund misappropriation amounting to 179,662,019.54 yuan, which represents 92.08% of its most recent audited net assets [4]. Group 3: Investor Compensation - Investors who purchased Long Pharmaceutical Holdings stock between March 30, 2019, and April 30, 2024, and sold or held their shares after April 30, 2024, are eligible to file for compensation based on previous successful judgments [5].

Core Viewpoint - The ongoing investor compensation case against Changyao Holdings (300391) is driven by allegations of false statements, with a precedent of investor victories in similar claims [1][2][3] Group 1: Legal Proceedings - Changyao Holdings has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into false financial reporting, leading to a formal case being opened [3] - The law firm Shanghai Jiucheng has filed a compensation case on behalf of investors with the Wuhan Intermediate People's Court, awaiting further court arrangements [1][2] - Investors who purchased Changyao Holdings stock between March 30, 2019, and April 30, 2024, and sold or held the stock after April 30, 2024, are eligible to initiate compensation claims [2][4] Group 2: Financial Issues - Changyao Holdings reported a significant fund occupation amounting to 179,662,019.54 yuan, which represents 92.08% of the company's most recent audited net assets [4] - The company plans to clear the occupied funds through the transfer of debts and credits with related parties [4] - An audit report from Zhongshun Yatai Accounting Firm highlighted major uncertainties regarding the company's ongoing operations, indicating serious financial concerns [3]

Core Viewpoint - The actual controller of Qingyue Technology has withdrawn the share repurchase proposal due to an ongoing investigation by the regulatory authorities, aiming to protect investors' rights [1]. Group 1: Share Repurchase Proposal - On November 4, Qingyue Technology announced a proposal from its actual controller, Gao Yudi, to repurchase shares using self-owned funds, with a total amount between 10 million and 20 million RMB [3][4]. - On December 12, the company disclosed that Gao Yudi decided to withdraw the share repurchase proposal amid the investigation [1][4]. Group 2: Legal and Financial Implications - The company is facing risks of civil lawsuits due to false financial data disclosures, which could lead to civil compensation liabilities [5]. - Gao Yudi has voluntarily committed to bear a minimum of 10 million RMB in potential civil compensation if the company is sued and found liable [5]. - To secure this commitment, Gao Yudi has pledged part of his shares in the company [5]. Group 3: Company Overview - Qingyue Technology specializes in the research, production, and sales of new display devices, primarily focusing on PMOLED, electronic paper modules, and silicon-based OLED micro-displays [5]. - The company's products are utilized in various sectors, including smart home, healthcare, automotive control, consumer electronics, wearable displays, retail, and near-eye display XR [5]. Group 4: Stock Performance - As of December 12, Qingyue Technology's stock price reached a new low of 6.05 RMB per share, with a market capitalization of approximately 2.7 billion RMB [6].

Core Viewpoint - Suzhou Qingyue Optoelectronics Technology Co., Ltd. is under investigation by the China Securities Regulatory Commission (CSRC) for suspected false reporting of financial data, which may lead to severe penalties including potential delisting from the Shanghai Stock Exchange if violations are confirmed [1][2]. Group 1 - The company disclosed on November 1, 2025, that it received a notice of investigation from the CSRC due to allegations of false financial reporting [1]. - The CSRC's investigation is ongoing, and the company has not yet received a conclusive opinion or decision regarding the investigation [1]. - If the investigation confirms significant violations, the company may face mandatory delisting under the rules of the Shanghai Stock Exchange [1]. Group 2 - The company emphasizes that its operational management, business, and financial status remain normal despite the investigation [2]. - The company is committed to cooperating with the CSRC and will provide monthly updates on the investigation's progress through risk disclosure announcements [2]. - Designated media for information disclosure include the Shanghai Stock Exchange website and several financial newspapers, ensuring that all relevant announcements are made public [2].

Core Points - *ST Changyao (300391.SZ) experienced a decline of 9.34%, closing at 2.33 yuan, with a total market capitalization of 816.3 million yuan [1] - The company received a "Notice of Investigation" from the China Securities Regulatory Commission (CSRC) on November 7, 2025, due to suspected false reporting of financial data [1] - If the CSRC's subsequent administrative penalties confirm the violations, the company may face mandatory delisting under the Shenzhen Stock Exchange's rules for major violations [1]

Core Viewpoint - *ST Changyao has been under investigation by the China Securities Regulatory Commission (CSRC) for suspected false reporting of financial data, which could lead to a forced delisting if major violations are confirmed [2]. Financial Performance - As of December 31, 2024, *ST Changyao reported a negative net asset of 433 million yuan and an accumulated loss of 1.59 billion yuan [2]. - In the first three quarters of 2025, the company's revenue increased by 4.40% year-on-year to 105 million yuan, while the net profit attributable to shareholders decreased by 15.89% to -210 million yuan [2]. - The net profit excluding non-recurring items fell by 16.99% to -209 million yuan, with net assets further declining to -643 million yuan [2]. Stock Performance - As of November 7, *ST Changyao's stock price was 3.45 yuan per share, down 0.58%, with a total market capitalization of 1.209 billion yuan [2][3]. - The stock has shown a trading volume of 75,300 shares, with a turnover rate of 2.15% [3].

Core Points - Company received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into suspected false financial reporting [1] - The investigation is related to the company's periodic reports and financial data [1] - If the investigation leads to a determination of significant violations, the company may face mandatory delisting due to serious misconduct [1]